Scan kids with caution Male pattern baldness linked to prostate cancerBut finger-length ratio not a risk factor, Canadian study shows Statins may slow prostate growth Finding emerges from secondary analysis of dutasteride trial Target colorectal screening based on life expectancy Analysis shows lag-time for benefit exceeds 10 years Chemoradiotherapy superior in muscle-invasive bladder cancer Radiation alone is inferior, ‘remarkable’ study shows Here’s to self-experimentation Doctors down an antioxidant drink aimed at curbing radiation damage Bacterium linked with colon cancer Finding could have implications for diagnosis and treatment Too many colonoscopies? Followup intervals are too short, study suggests Xalkori for non-small-cell lung cancer New personalized therapy is for managing a specific type of non-small-cell lung cancer. Bladder cancer risk seen with pioglitazone Drug used to treat type 2 diabetes may carry a small risk of bladder cancer. Endometrial cancer needs a rethink Consortium aims for global impact in improving tumour classification New study examines cancer risk with ARBs Previous experimental work had raised theoretical concerns about the risk of cancer, since ARBs play a role in regulating angiogenesis, cell proliferation, and tumour progression. First Previous 50 51 52 53 54 Next Last
